Literature DB >> 22296655

Abdominal ultrasonographic findings at diagnosis of osteosarcoma in dogs and association with treatment outcome.

O Sacornrattana1, N G Dervisis, E A McNiel.   

Abstract

The purpose of this study was to describe abdominal ultrasonographic findings present at diagnosis of osteosarcoma (OSA) in dogs and to investigate for associations with treatment outcome. Medical records from 118 dogs diagnosed with OSA that had abdominal ultrasonography performed as part of their initial evaluation were reviewed. Fifty-seven percent had ultrasonographic abnormalities identified. The organ with the highest frequency of ultrasonographic changes was the spleen. While most sonographic changes were considered to be either benign or of unknown clinical consequences, metastases were identified in three dogs (2.5%), two of which (1.7%) did not have other evidence of metastasis. Dogs with any ultrasonographic abnormality were less likely to receive definitive therapy (P = 0.005) and exhibited shorter survival, although the latter observation was not statistically significant (P = 0.071). However, the identification of lesions in either the liver (P = 0.021) or the kidney (P = 0.003) was statistically associated with shorter survival.
© 2012 John Wiley & Sons Ltd.

Entities:  

Keywords:  abdominal ultrasound; canine; metastasis; osteosarcoma

Mesh:

Year:  2012        PMID: 22296655     DOI: 10.1111/j.1476-5829.2011.00312.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  4 in total

1.  Impact of Toceranib/Piroxicam/Cyclophosphamide Maintenance Therapy on Outcome of Dogs with Appendicular Osteosarcoma following Amputation and Carboplatin Chemotherapy: A Multi-Institutional Study.

Authors:  Cheryl A London; Heather L Gardner; Tamra Mathie; Nicole Stingle; Roberta Portela; Michael L Pennell; Craig A Clifford; Mona P Rosenberg; David M Vail; Laurel E Williams; Kim L Cronin; Heather Wilson-Robles; Antonella Borgatti; Carolyn J Henry; Dennis B Bailey; Jennifer Locke; Nicole C Northrup; Martin Crawford-Jakubiak; Virginia L Gill; Mary K Klein; David M Ruslander; Doug H Thamm; Brenda Phillips; Gerald Post
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

2.  Effect of screening abdominal ultrasound examination on the decision to pursue advanced diagnostic tests and treatment in dogs with neurologic disease.

Authors:  N M Tong; A L Zwingenberger; W H Blair; S L Taylor; R X Chen; B K Sturges
Journal:  J Vet Intern Med       Date:  2015-04-21       Impact factor: 3.333

3.  Cutaneous and subcutaneous metastasis of appendicular osteosarcoma in dogs: 20 cases.

Authors:  Cyril Parachini-Winter; Kaitlin M Curran; MacKenzie Pellin; Travis Laver; Camille Hanot; Timothy H Vernier; Bernard Séguin
Journal:  J Vet Intern Med       Date:  2019-07-11       Impact factor: 3.333

4.  Pharmacokinetic study and evaluation of the safety of taurolidine for dogs with osteosarcoma.

Authors:  Kevin Marley; Stuart C Helfand; Jennifer Simpson; John E Mata; William G Tracewell; Lisa Brownlee; Shay Bracha; Bernard Séguin
Journal:  J Exp Clin Cancer Res       Date:  2013-10-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.